Abstract

Placental villi play pivotal roles in feto-maternal transportation and phospholipids constitute a major part of the villous membrane. We have been developing and optimizing an imaging system based on a matrix-assisted laser desorption/ionization (MALDI)-based mass spectrometer, which provides clear two-dimensional molecular distribution patterns using highly sensitive mass spectrometry from mixtures of ions generated on tissue surfaces. We recently applied this technology to normal human uncomplicated term placentas and detected the specific distribution of sphingomyelin (SM) (d18:1/16:0) in stem villi and phosphatidylcholine (PC) (16:0/20:4) in terminal villi. In the present study, we applied this technology to nine placentas with maternal or fetal complications, and determined whether a relationship existed between these specific distribution patterns of phospholipid molecules and the six representative pathological findings of placentas, i.e., villitis of unknown etiology (VUE), thrombus, atherosis, chorioamnionitis (CAM), immature terminal villi, and multiple branched terminal villi. In two placentas with the first and second largest total number of positive pathological findings, i.e., five and three positive findings, the specific distribution of SM (d18:1/16:0) in stem villi and PC (16:0/20:4) in terminal villi disappeared. The common pathological findings in these two placentas were atherosis, immature terminal villi, and multiple branched terminal villi, suggesting the possible involvement of the underperfusion of maternal blood into the intervillous space. On the other hand, the number of pathological findings were two or less in the seven other placentas, in which no specific relationships were observed between the differential expression patterns of these two phospholipids in stem and terminal villi and the pathological findings of the placentas; however, the specific distribution pattern of SM (d18:1/16:0) in stem villi disappeared in four placentas, while that of PC (16:0/20:4) in terminal villi was preserved. These results suggested that the absence of the specific distribution of PC (16:0/20:4) in terminal villi, possibly in combination with the absence of SM (d18:1/16:0) in stem villi, was linked to placental morphological changes in response to maternal underperfusion of the placenta.

Highlights

  • The placenta is the largest fetal organ and links the mother to the fetus

  • villitis of unknown etiology (VUE) was observed in placenta No 1, thrombus in placenta No 4, atherosis in placenta Nos. 1 and 2, CAM in placenta Nos. 1, 3, and 5, immature terminal villi in placenta Nos.1-3 and 8, and multiple branched terminal villi in placenta Nos. 1, 2, 4–7, and 9

  • Our previous imaging mass spectrometry (IMS) analysis of normal uncomplicated term placentas showed that SM (d18:1/16:0) was distributed in stem villi, but not in terminal villi, and that PC (16:0/20:4) was distributed in terminal villi, but not in stem villi [21]

Read more

Summary

Introduction

Placental villi play pivotal roles in the supply of nutrients and oxygen from the mother, thereby enabling proper fetal development and functions [1], and form a barrier to toxins and infective organisms in order to protect fetal organs [2]. These villi are the main contributor to the expression of various kinds of bioactive substances that maintain pregnancy, including human chorionic gonadotropin, progesterone, estradiol, estriol, leptin, and resistin [3]. Percy et al, extracted lipids from human placentas and reported significant differences in the composition of PC and acylglycerol between placentas from growth-restricted and normally grown newborns [10]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call